Matches in SemOpenAlex for { <https://semopenalex.org/work/W2596882783> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2596882783 abstract "Abstract Abstract 2509 Poster Board II-486 Acute radiation syndrome and therapeutic radiation are associated with cytopenias, notably severe neutropenia, particularly when large regions of bone marrow are exposed. An orally-active neutrophil stimulant which reduces the duration or magnitude of neutropenia would offer therapeutic benefit in radiation therapy and would be useful for acute radiation exposure. Orally-bioavailable short-chain fatty acid derivatives (SCFAD, HemokinesTM HQK-1002 and its S-enantiomer HQK-1002S), which stimulate proliferation of growth factor-dependent hematopoietic cell lines and CFU-GM cultures, were evaluated for in vivo activity in irradiated and 5-FU-treated mice and in normal baboons. In sub-lethal irradiation studies, mice were irradiated (6 Gy single dose) and then treated with saline or HQK-1002 once daily, 5 days/week for 2 weeks, beginning on day 1 after irradiation, and absolute neutrophil counts (ANC) were determined. The mean nadir of absolute neutrophil counts (ANC) <500/mm3 was 6 days in sub-lethally-irradiated mice treated with HQK-1002, and 18 days in the saline treated controls. In HQK-1002 treated mice, ANC did not decline below 200/mm3, while saline-treated animals experienced 10 days of severe neutropenia with ANC <200/mm3. In lethally-irradiated (LD90) mice, either saline or the (S) enantiomer of HQK-1002 was administered daily. ANC and marrow pathology were compared between saline and HQK-1002S-treated animals. The duration of peripheral neutropenia was similar in controls and HQK-1002S-treated animals, but bone marrow pathology demonstrated profound ablation of all mature myeloid series (10-20% cellularity) in the saline controls, while HQK-1002S-treated animals had normal bone marrow cellularity (55–75%) with complete neutrophil maturation within 2 weeks following radiation. In 5FU-treated mice, neutrophil recovery was compared between HQK-1002, saline, or G-CSF treatment for 3 weeks. Recovery from profound neutropenia (nadir at Day 9) occurred by Day 13 in G-CSF- and HQK-1002 treated animals, 5 days before recovery was observed in saline controls. HQK-1002 and HQK-1002S were also administered to non-irradiated, normal juvenile baboons, once daily for 5 days, and CBCs and neutrophil counts were assayed. HQK-1002 or HQK-1002S treatment in 3 unchallenged baboons resulted in a two-fold to three-fold rises in ANC within 7 days. Collectively, these studies strongly suggest that HQK-1002 and HQK-1002S, orally-bioavailable SCFADs, stimulate myelopoiesis in vivo in normal animals and during sub-lethal radiation-induced bone marrow suppression, and merit further evaluation in neutropenia associated with marrow suppression. Disclosures: Perrine: HemaQuest Pharmaceuticals: Employment, Equity Ownership, Patents & Royalties, Research Funding. Boosalis:HemaQuest Pharmaceuticals: Equity Ownership. Thomson:HemaQuest Pharmaceuticals: Employment, Equity Ownership. Berenson:hemaQuest Pharmaceuticals: Employment, Equity Ownership, Membership on an entity's Board of Directors or advisory committees. Faller:HemaQuest Pharmaceuticals: Consultancy, Equity Ownership, Patents & Royalties, Research Funding." @default.
- W2596882783 created "2017-03-23" @default.
- W2596882783 creator A5032470452 @default.
- W2596882783 creator A5038957092 @default.
- W2596882783 creator A5057101829 @default.
- W2596882783 creator A5060134012 @default.
- W2596882783 creator A5066604419 @default.
- W2596882783 creator A5068218416 @default.
- W2596882783 creator A5083735394 @default.
- W2596882783 creator A5086539163 @default.
- W2596882783 creator A5089752700 @default.
- W2596882783 creator A5090627199 @default.
- W2596882783 date "2009-11-20" @default.
- W2596882783 modified "2023-10-01" @default.
- W2596882783 title "A Multi-Lineage Oral Hemokine™ HQK-1002 Enhances Neutrophil Recovery in Sub-Lethally Irradiated Mice and in Baboons." @default.
- W2596882783 doi "https://doi.org/10.1182/blood.v114.22.2509.2509" @default.
- W2596882783 hasPublicationYear "2009" @default.
- W2596882783 type Work @default.
- W2596882783 sameAs 2596882783 @default.
- W2596882783 citedByCount "0" @default.
- W2596882783 crossrefType "journal-article" @default.
- W2596882783 hasAuthorship W2596882783A5032470452 @default.
- W2596882783 hasAuthorship W2596882783A5038957092 @default.
- W2596882783 hasAuthorship W2596882783A5057101829 @default.
- W2596882783 hasAuthorship W2596882783A5060134012 @default.
- W2596882783 hasAuthorship W2596882783A5066604419 @default.
- W2596882783 hasAuthorship W2596882783A5068218416 @default.
- W2596882783 hasAuthorship W2596882783A5083735394 @default.
- W2596882783 hasAuthorship W2596882783A5086539163 @default.
- W2596882783 hasAuthorship W2596882783A5089752700 @default.
- W2596882783 hasAuthorship W2596882783A5090627199 @default.
- W2596882783 hasConcept C109159458 @default.
- W2596882783 hasConcept C126322002 @default.
- W2596882783 hasConcept C142724271 @default.
- W2596882783 hasConcept C150903083 @default.
- W2596882783 hasConcept C203014093 @default.
- W2596882783 hasConcept C207001950 @default.
- W2596882783 hasConcept C2776694085 @default.
- W2596882783 hasConcept C2777063308 @default.
- W2596882783 hasConcept C2777397205 @default.
- W2596882783 hasConcept C2777767877 @default.
- W2596882783 hasConcept C2780007613 @default.
- W2596882783 hasConcept C28328180 @default.
- W2596882783 hasConcept C29730261 @default.
- W2596882783 hasConcept C54355233 @default.
- W2596882783 hasConcept C71924100 @default.
- W2596882783 hasConcept C74133956 @default.
- W2596882783 hasConcept C86803240 @default.
- W2596882783 hasConcept C98274493 @default.
- W2596882783 hasConceptScore W2596882783C109159458 @default.
- W2596882783 hasConceptScore W2596882783C126322002 @default.
- W2596882783 hasConceptScore W2596882783C142724271 @default.
- W2596882783 hasConceptScore W2596882783C150903083 @default.
- W2596882783 hasConceptScore W2596882783C203014093 @default.
- W2596882783 hasConceptScore W2596882783C207001950 @default.
- W2596882783 hasConceptScore W2596882783C2776694085 @default.
- W2596882783 hasConceptScore W2596882783C2777063308 @default.
- W2596882783 hasConceptScore W2596882783C2777397205 @default.
- W2596882783 hasConceptScore W2596882783C2777767877 @default.
- W2596882783 hasConceptScore W2596882783C2780007613 @default.
- W2596882783 hasConceptScore W2596882783C28328180 @default.
- W2596882783 hasConceptScore W2596882783C29730261 @default.
- W2596882783 hasConceptScore W2596882783C54355233 @default.
- W2596882783 hasConceptScore W2596882783C71924100 @default.
- W2596882783 hasConceptScore W2596882783C74133956 @default.
- W2596882783 hasConceptScore W2596882783C86803240 @default.
- W2596882783 hasConceptScore W2596882783C98274493 @default.
- W2596882783 hasLocation W25968827831 @default.
- W2596882783 hasOpenAccess W2596882783 @default.
- W2596882783 hasPrimaryLocation W25968827831 @default.
- W2596882783 hasRelatedWork W1988495233 @default.
- W2596882783 hasRelatedWork W2010572771 @default.
- W2596882783 hasRelatedWork W2079323472 @default.
- W2596882783 hasRelatedWork W2085753838 @default.
- W2596882783 hasRelatedWork W2151286079 @default.
- W2596882783 hasRelatedWork W2167210662 @default.
- W2596882783 hasRelatedWork W2171869533 @default.
- W2596882783 hasRelatedWork W2288110886 @default.
- W2596882783 hasRelatedWork W2347959328 @default.
- W2596882783 hasRelatedWork W2358278677 @default.
- W2596882783 hasRelatedWork W2369008620 @default.
- W2596882783 hasRelatedWork W2377045412 @default.
- W2596882783 hasRelatedWork W2382935625 @default.
- W2596882783 hasRelatedWork W2412050976 @default.
- W2596882783 hasRelatedWork W2417112802 @default.
- W2596882783 hasRelatedWork W2418946742 @default.
- W2596882783 hasRelatedWork W2419461475 @default.
- W2596882783 hasRelatedWork W2579790390 @default.
- W2596882783 hasRelatedWork W3031738616 @default.
- W2596882783 hasRelatedWork W87006817 @default.
- W2596882783 isParatext "false" @default.
- W2596882783 isRetracted "false" @default.
- W2596882783 magId "2596882783" @default.
- W2596882783 workType "article" @default.